PGNY CEO Peter Anevski disposes 7,977 shares; holds 539,564

Rhea-AI Filing Summary

Progyny director and Chief Executive Officer Peter Anevski reported an insider transaction dated 10/01/2025. The Form 4 shows 7,977 shares of Progyny common stock were disposed of at a price of $21.52 per share, with the filer retaining beneficial ownership of 539,564 shares following the transaction. The filing explains the sale resulted from shares withheld to cover taxes on vested restricted stock units and notes the remaining reportable shares are held directly by PECO ANEVSKI 2020 SD LLC. The Form 4 was signed by an attorney-in-fact on 10/02/2025.

Positive

• Retains 539,564 shares of Progyny common stock after the transaction, indicating continued substantial ownership
• Sale attributed to tax withholding on vested RSUs, a routine administrative reason rather than a discretionary cash raise

Negative

• 7,977 shares disposed at $21.52 on 10/01/2025, representing an insider sale reported by the CEO

Insights

Corporate Governance & Insider Trading Expert

TL;DR: CEO sold 7,977 shares at $21.52; retains 539,564 shares, sale tied to tax withholding.

The Form 4 records a disposition of 7,977 shares on 10/01/2025 executed under a vesting tax-withholding event rather than a market-driven decision. Such withholdings are common when restricted stock units vest and do not necessarily indicate a change in management view.

The reporting also clarifies ownership structure: reportable shares are held directly by PECO ANEVSKI 2020 SD LLC, which is relevant for assessing control and potential future filings. The signature by an attorney-in-fact on 10/02/2025 completes the required disclosure.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Anevski Peter

(Last) (First) (Middle)

C/O PROGYNY, INC.

1359 BROADWAY, 2ND FLOOR

(Street)

NEW YORK NY 10018

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Progyny, Inc. [ PGNY ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CHIEF EXECUTIVE OFFICER

3. Date of Earliest Transaction (Month/Day/Year)
10/01/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	10/01/2025		F(1)		7,977	D	$21.52	539,564	D
Common Stock								1	I	See footnote(2)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Shares withheld for payment of withholding taxes upon the vesting of restricted stock units granted to the Reporting Person.

2. The reportable securities are held directly by the PECO ANEVSKI 2020 SD LLC.

Remarks:

	/s/ Mark Livingston, Attorney-in-Fact	10/02/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Progyny insider Peter Anevski report on Form 4 (PGNY)?

The Form 4 reports a disposition of 7,977 shares at $21.52 per share on 10/01/2025, with beneficial ownership of 539,564 shares remaining.

Why were the shares sold according to the Form 4?

The filing states the shares were withheld to cover payment of withholding taxes upon the vesting of restricted stock units granted to the reporting person.

Who holds the reportable securities for Anevski?

The reportable securities are held directly by PECO ANEVSKI 2020 SD LLC as disclosed in the Form 4.

When was the Form 4 signed and filed?

The Form 4 was signed by an attorney-in-fact on 10/02/2025 and reports the transaction dated 10/01/2025.

Does the Form 4 indicate any new derivative positions?

No. The filing lists only non-derivative common stock transactions and contains no new derivative securities.